Skip to Main Content
Your Community. Your Stories.

KentStater

World and Nation:
Your Community. Your Stories.

KentStater

Your Community. Your Stories.

KentStater

Illustration by Emily Riebe

Usage of GLP-1 drugs raises question of gender disparity

Sascha Aleksich, Reporter March 26, 2025

Women are substantially more likely to consider taking GLP-1 drugs like Ozempic, a medication originally used to treat type 2 diabetes, to lose weight, compared to men. With about 51% of women showing...

Popular semaglutide injections from drug manufacturer Novo Nordisk are no longer in shortage, according to the FDA.

Ozempic and Wegovy are no longer in shortage, FDA says

Deidre McPhillips, CNN February 21, 2025

(CNN) — Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. The update about the popular semaglutide injections...

Activate Search
Your Community. Your Stories.
Ozempic